Physician profile
Barry A Solomon
NPI 1740242031
$1,003.09
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $214 · 2021: $15.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $135.84 | 2019-2020 | |
| Pfizer INC. | $124.61 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $120.18 | 2019-2020 | |
| Abbvie INC. | $118.34 | 2019-2020 | |
| Almirall LLC | $84.55 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $81.06 | 2019-2020 | |
| Lilly USA, LLC | $67.43 | 2019 | |
| Genentech USA, INC. | $55.03 | 2019 | |
| Ucb, INC. | $43.70 | 2019 | |
| Genzyme Corporation | $42.85 | 2019 | |
| Dermira, INC. | $27.44 | 2020 | |
| Leo Pharma INC. | $23.71 | 2019 | |
| Epi Health, LLC | $21.66 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.17 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $19.02 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.50 | 2020 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.